Illumina (ILMN) is a publicly traded Healthcare sector company. As of November 17, 2026, ILMN trades at $200.50 with a market cap of $31.30B and a P/E ratio of 51.12. ILMN moved -4.43% today. Year to date, ILMN is +47.37%; over the trailing twelve months it is +64.07%. Its 52-week range spans $68.70 to $309.35. Analyst consensus is buy with an average price target of $263.59. Rallies surfaces ILMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Illumina (ILMN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ILMN moved -4.43% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $200.50 |
| Market Cap | $31.30B |
| P/E Ratio | 51.12 |
| EPS | $5.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $309.35 |
| 52-Week Low | $68.70 |
| Volume | 1.20M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.49B |
| Net Income | $824.00M |
| Gross Margin | 66.38% |
18 analysts cover ILMN: 0 strong buy, 9 buy, 6 hold, 3 sell, 0 strong sell. Consensus rating is buy. Average price target: $263.59.